MiMedx Group, Inc. (MDXG)
NASDAQ: MDXG · IEX Real-Time Price · USD
6.20
-0.05 (-0.80%)
Apr 26, 2024, 10:50 AM EDT - Market open
MiMedx Group Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for MiMedx Group stock have an average target of 12.25, with a low estimate of 11 and a high estimate of 14. The average target predicts an increase of 97.74% from the current stock price of 6.20.
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 7, 2024.
Analyst Ratings
The average analyst rating for MiMedx Group stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 4 | 4 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Lake Street | Lake Street | Strong Buy Initiates $12 | Strong Buy | Initiates | $12 | +93.70% | Mar 7, 2024 |
| Mizuho | Mizuho | Strong Buy Maintains $13 → $14 | Strong Buy | Maintains | $13 → $14 | +125.99% | Mar 1, 2024 |
| Mizuho | Mizuho | Strong Buy Maintains $14 → $12 | Strong Buy | Maintains | $14 → $12 | +93.70% | Oct 31, 2023 |
| Craig-Hallum | Craig-Hallum | Strong Buy Initiates $12 | Strong Buy | Initiates | $12 | +93.70% | Oct 27, 2023 |
| Mizuho | Mizuho | Strong Buy Maintains $10 → $12 | Strong Buy | Maintains | $10 → $12 | +93.70% | Aug 2, 2023 |
Financial Forecast
Revenue This Year
364.26M
from 321.48M
Increased by 13.31%
Revenue Next Year
411.44M
from 364.26M
Increased by 12.95%
EPS This Year
0.31
from 0.37
Decreased by -15.09%
EPS Next Year
0.40
from 0.31
Increased by 26.62%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 381.4M | 440.2M | 482.5M | 521.1M | 579.9M |
| Avg | 364.3M | 411.4M | 460.8M | 506.3M | 563.3M |
| Low | 347.0M | 384.3M | 435.1M | 486.4M | 541.2M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 18.6% | 20.8% | 17.3% | 13.1% | 14.5% |
| Avg | 13.3% | 13.0% | 12.0% | 9.9% | 11.3% |
| Low | 7.9% | 5.5% | 5.7% | 5.6% | 6.9% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 0.37 | 0.46 | 0.57 |
| Avg | 0.31 | 0.40 | 0.54 |
| Low | 0.27 | 0.34 | 0.50 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -0.7% | 47.1% | 42.5% |
| Avg | -15.1% | 26.6% | 34.6% |
| Low | -25.8% | 9.2% | 25.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.